Renovorx Inc is a biotechnology company focused on developing innovative therapeutics designed to address unmet needs in the field of chronic diseases
The company specializes in the creation of targeted treatment delivery systems, with an emphasis on utilizing proprietary technologies to improve the efficacy and safety of existing therapies. By harnessing advanced drug formulations and delivery mechanisms, Renovorx aims to enhance patient outcomes and quality of life through personalized medicine strategies. Their commitment to research and development positions them at the forefront of modern biomedical advancements, working to bring transformative solutions to patients suffering from complex health conditions.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
RenovoRx, Inc. (NASDAQRNXT) shares are trading higher Thursday after the company released interim data on progression-free survival from Phase 3 open label TIGeR-PaC study of RenovoGem
